DH, L., A, K., T, M., LC, P., M, A., C, B., . . . DK, H. (2023). Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma. Blood advances, 7(16), 4247. https://doi.org/10.1182/bloodadvances.2023009766
Chicago Style (17th ed.) CitationDH, Lee, et al. "Cardiac Events After Standard of Care Idecabtagene Vicleucel for Relapsed and Refractory Multiple Myeloma." Blood Advances 7, no. 16 (2023): 4247. https://doi.org/10.1182/bloodadvances.2023009766.
MLA (9th ed.) CitationDH, Lee, et al. "Cardiac Events After Standard of Care Idecabtagene Vicleucel for Relapsed and Refractory Multiple Myeloma." Blood Advances, vol. 7, no. 16, 2023, p. 4247, https://doi.org/10.1182/bloodadvances.2023009766.
Warning: These citations may not always be 100% accurate.
